CRYOPORT, INC. Cash
CRYOPORT, INC. (CYRX) had Cash of $38.42 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-06
- 2026-06-30: Cash $38.42M.
- 2026-03-31: Cash $42.20M.
- 2025-12-31: Cash $42.37M.
- 2025-09-30: Cash $39.34M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2026-06-30 | $38.42M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $42.20M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $42.37M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $39.34M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $38.94M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $32.95M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $34.00M 10-K · filed 2026-03-05 | $45.16M 10-K · filed 2025-03-07 |
| 2024-09-30 | $44.04M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $40.99M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $42.58M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $40.98M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $40.76M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $34.17M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $36.00M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $34.75M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $28.87M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $28.76M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $32.65M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $27.79M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $29.30M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $29.61M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $23.91M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $25.05M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $69.35M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $16.97M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $6.54M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $3.55M 10-K · filed 2021-03-01 | $3.55M 10-K · filed 2020-03-10 |
| 2019-09-30 | $3.23M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $79.47M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $32.15M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $37.22M 10-K · filed 2020-03-10 | |
| 2018-06-30 | $19.80M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $18.70M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $14.80M 10-K · filed 2018-03-08 | |
| 2016-12-31 | $4.30M 10-KT · filed 2017-03-13 | |
| 2016-03-31 | $2.60M 10-K · filed 2016-06-28 | |
| 2015-03-31 | $1.30M 10-K · filed 2016-06-28 | |
| 2014-03-31 | $159.00K 10-K · filed 2015-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |